FDA-approved Weight Loss Medications

Novo Nordisk’s Ozempic Gets FDA Approval

Ozempic Approved By FDA For Kidney Disease—In Ultra-Popular Drug’s Latest Approval

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and strokes.

CNBC on MSN · 15h

FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a gradual loss of kidney function.

The Wall Street Journal on MSN · 15h

Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type 2 diabetes and chronic kidney disease, Novo Nordisk said.

U.S. News & World Report · 15h

US FDA Approves Novo Nordisk's Ozempic to Cut Risk of Diabetic Kidney Disease Progression

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),

12h

Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

19hon MSN

The Health Risks and Benefits of Weight-Loss Drugs

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

13h

Oprah Winfrey shares the type of weight loss medication she took

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

11d

Outgoing FDA chief flags online weight loss drug dangers

Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...

6don MSN

Massive study looks at benefits, risks of GLP-1 weight-loss drugs

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

11d

Mounjaro vs. Ozempic: Which One Is Best for Me to Try for Weight Loss in 2025?

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

11d

E-sellers of compounded weight-loss drugs fail to reveal risks, research shows

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

Yahoo News6d

The FDA is about to make weight-loss drugs a lot harder to get

Her doctor prescribed the cheaper, generic version of the weight-loss drug after her insurer ... to stop making compounded versions of the drug — meaning the only version available will be the ...

Medscape5d

Obesity Medications: Who Needs Priority Access

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results